A response usually is seen within 48 to 72 hours, with brisk production of new red blood cells
The treatment is generally well-tolerated, with manageable side effects, and is administered via once-weekly subcutaneous injections, promoting patient adherence and consistent usage
Quick Reference: Standard Protocol Draw volumes reflect community-documented reconstitution protocols, not a recommended dosing schedule
(the significance of a high cobalaminconcentration in blood) Ermens AAM, Vlasveld LTh, Van Marion-Kievit JA, Lensen CJPA, Lindemans J
He noted that while the study was relatively short term, the effect was clear and said the once-daily pill could be particularly attractive as an option for people living with diabetes not wanting injectable therapy